XML 74 R55.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions, Divestitures and Other Arrangements - Summary of Fair Values of Assets Acquired (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Jul. 31, 2021
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]      
Total consideration $ 399,617 $ 328,202  
Construction in Process [Member]      
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]      
Total consideration 88,825 28,210  
Buildings [Member]      
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]      
Total consideration 173,560 174,209  
Furniture and Fixtures [Member]      
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]      
Total consideration $ 20,318 $ 19,318  
EirGen Pharma Limited [Member]      
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]      
Total consideration     $ 67,944
EirGen Pharma Limited [Member] | Construction in Process [Member]      
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]      
Total consideration     22,736
EirGen Pharma Limited [Member] | Buildings [Member]      
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]      
Total consideration     21,550
EirGen Pharma Limited [Member] | Furniture and Fixtures [Member]      
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]      
Total consideration     1,089
EirGen Pharma Limited [Member] | Other [Member]      
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]      
Total consideration     775
EirGen Pharma Limited [Member] | Definite-Lived Intangible Assets [Member]      
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]      
Total consideration     $ 21,794